These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24711254)

  • 1. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia.
    O'Malley KJ; Eisermann K; Pascal LE; Parwani AV; Majima T; Graham L; Hrebinko K; Acquafondata M; Stewart NA; Nelson JB; Yoshimura N; Wang Z
    Prostate; 2014 Jun; 74(8):892-900. PubMed ID: 24711254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.
    Li F; Pascal LE; Stolz DB; Wang K; Zhou Y; Chen W; Xu Y; Chen Y; Dhir R; Parwani AV; Nelson JB; DeFranco DB; Yoshimura N; Balasubramani GK; Gingrich JR; Maranchie JK; Jacobs BL; Davies BJ; Hrebinko RL; Bigley JD; McBride D; Guo P; He D; Wang Z
    Prostate; 2019 Aug; 79(11):1226-1237. PubMed ID: 31212363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.
    Chen W; Pascal LE; Wang K; Dhir R; Sims AM; Campbell R; Gasper G; DeFranco DB; Yoshimura N; Wang Z
    Prostate; 2020 Oct; 80(14):1177-1187. PubMed ID: 32659026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta 1 impairs benign prostatic luminal epithelial cell monolayer barrier function.
    Li F; Pascal LE; Wang K; Zhou Y; Balasubramani GK; O'Malley KJ; Dhir R; He K; Stolz D; DeFranco DB; Yoshimura N; Nelson JB; Chong T; Guo P; He D; Wang Z
    Am J Clin Exp Urol; 2020; 8(1):9-17. PubMed ID: 32211449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia.
    He Y; Ou Z; Chen X; Zu X; Liu L; Li Y; Cao Z; Chen M; Chen Z; Chen H; Qi L; Wang L
    Sci Rep; 2016 May; 6():27051. PubMed ID: 27243216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating spatial transcriptomics and single-cell RNA-sequencing reveals the alterations in epithelial cells during nodular formation in benign prostatic hyperplasia.
    Fei X; Liu J; Xu J; Jing H; Cai Z; Yan J; Wu Z; Li H; Wang Z; Shen Y
    J Transl Med; 2024 Apr; 22(1):380. PubMed ID: 38654277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia.
    O'Malley KJ; Dhir R; Nelson JB; Bost J; Lin Y; Wang Z
    Prostate; 2009 Dec; 69(16):1716-23. PubMed ID: 19676094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
    Wang K; Pascal LE; Li F; Chen W; Dhir R; Balasubramani GK; DeFranco DB; Yoshimura N; He D; Wang Z
    Prostate; 2020 Oct; 80(14):1203-1215. PubMed ID: 32692865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
    Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.
    Lin VK; Wang SY; Boetticher NC; Vazquez DV; Saboorian H; McConnell JD; Roehrborn CG
    Prostate; 2005 May; 63(3):299-308. PubMed ID: 15611997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
    Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
    Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal-AR influences the growth of epithelial cells in the development of benign prostate hyperplasia.
    Chauhan G; Mehta A; Gupta S
    Mol Cell Biochem; 2020 Aug; 471(1-2):129-142. PubMed ID: 32504365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia.
    Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Wolfert RL; Marks LS; Song W; Wheeler TM; Slawin KM
    Urology; 2000 Jan; 55(1):41-5. PubMed ID: 10654892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia.
    Mori F; Tanigawa K; Endo K; Minamiguchi K; Abe M; Yamada S; Miyoshi K
    Prostate; 2011 Oct; 71(14):1579-86. PubMed ID: 21394740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer.
    Zenzmaier C; Sampson N; Plas E; Berger P
    Prostate; 2013 Sep; 73(13):1441-52. PubMed ID: 23765731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.